Little news from the Jefferies Healthcare Conference on June 7, 2023:
"Full recruitment as early as Dec 2023."
=> But no update on % of enrollment achieved at this point of time.
"Topline data Q1 2023."
=> But again no mentioning any more of being "financed through topline data".
Interesting snippets:
"Both trials are tracking pretty similarly. So both trials will read out at the same time."
"Topline readout will contain both change in BCVA and retinal thickness / OCT data."
My best guess is a straight CR or use of the $75M ATM programme right after full enrollment, that's probably in Q1 2024.
Ann: Opthea Presents at the Jefferies 2023 Healthcare Conference, page-2
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.005(1.32%) |
Mkt cap ! $409.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.0¢ | $728.0K | 1.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 144551 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 6300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |